U.S. Software Stock News

Bladex earnings and dividend decision set the stage for investors Bladex (BLX) stock is back in focus after the bank reported second quarter 2026 results alongside a new quarterly dividend decision, giving investors fresh numbers on profitability and cash returns. See our latest analysis for Bladex. The latest earnings and dividend news comes after a strong period for Bladex, with the share price up 30.05% year to date and a 1 year total shareholder return of 42.66%. The recent 1 month share...

Intercontinental Exchange (ICE) reported July 2026 operating metrics that show higher trading activity across its markets, with total average daily volume up 25% year on year and open interest up 18%. See our latest analysis for Intercontinental Exchange. The stronger July trading metrics arrive after a busy few weeks for Intercontinental Exchange, which included second quarter earnings, a higher quarterly dividend and ongoing share buybacks. Even with this backdrop, the stock’s recent 30 day...

Abercrombie & Fitch recently marked its Fall 2026 denim campaign with a New York event featuring style figures such as Paloma Elsesser and Emily Ratajkowski, underscoring the brand’s emphasis on fashion identity and urban roots. At the same time, investors are watching the company’s upcoming August 26, 2026 earnings release, with analyst expectations of higher revenue but lower earnings per share and a valuation that screens favorably against industry peers. Next, we will examine how...

Tecnoglass Holdings Inc. has already reported its second-quarter 2026 results, with record revenue of US$295.29 million but lower net income of US$24.56 million and diluted EPS of US$0.55 compared with the prior year, alongside narrowed full-year 2026 revenue guidance of US$1.08 billion to US$1.12 billion. Behind the headline revenue records, the company is contending with higher aluminum costs and Colombian peso strength, which, together with its recent U.S. redomiciliation and shifting...

Kodiak Sciences has completed enrollment of the first 300-patient cohort in its Phase 3 PEAK trial of KSI-101 for macular edema secondary to inflammation, advancing a bispecific IL-6/VEGF therapy through a pivotal analysis that will inform regulatory paths. An interesting aspect of this update is how PEAK and the complementary PINNACLE study are structured to span a broad spectrum of MESI severity, from mild to more advanced disease, potentially broadening the therapy’s clinical relevance if...

In early August 2026, Tarsus Pharmaceuticals reported second-quarter revenue of US$173.91 million and a net loss of US$18.55 million, while also raising full-year 2026 XDEMVY net product sales guidance to US$685 million–US$705 million. The earnings update highlighted strong XDEMVY uptake, with more than 700,000 patients treated since launch and an acquisition of Alkeus Pharmaceuticals to broaden Tarsus’ ophthalmology pipeline. We’ll now examine how this stronger XDEMVY sales outlook and...

Why Toast stock is back in focus Toast (TOST) is drawing fresh attention after announcing an expanded integration with Google for AI powered food ordering in Google Maps, alongside a new endorsement as a point of sale option by BWH Hotels. See our latest analysis for Toast. For context, Toast’s share price is US$34.48, with a 30 day share price return of 17.6% and a 90 day share price return of 42.54%, while the 1 year total shareholder return is down 19.96% and the 3 year total shareholder...

Solaris Energy Infrastructure, Inc. recently reported past second-quarter 2026 results showing sales of US$105.72 million and net income of US$20.49 million, alongside affirming a third-quarter dividend of US$0.12 per share, marking its 32nd consecutive payout. Despite year-on-year growth in revenue and net income for both the quarter and first half of 2026, diluted earnings per share from continuing operations eased slightly in the latest quarter, hinting at increased share count or mix...

In August 2026, BillionToOne, Inc. reported that second-quarter 2026 sales rose to US$109.45 million with net income of US$8.05 million, and reaffirmed its full-year 2026 revenue outlook of US$450.0 million to US$465.0 million compared with 2025. The shift from a small loss to positive earnings per share across both the quarter and first half highlights a meaningful improvement in profitability alongside rapid revenue expansion. We’ll now examine how BillionToOne’s strong shift to...

Kiniksa Pharmaceuticals International, plc recently reported its second-quarter 2026 results, with revenue of US$243.6 million and net income of US$25.43 million, and raised its full-year 2026 net product revenue guidance to a range of US$980 million to US$995 million from US$930 million to US$945 million. The combination of higher guidance and year-on-year growth in revenue and earnings per share highlights management’s increased confidence in the durability of the company’s current...

Event driven focus on Autodesk stock Autodesk (ADSK) is back in the spotlight after recent work on discounted cash flow valuation, the integration of MaintainX, and steady fiscal Q2 sales trends during restructuring, all ahead of the 27 August 2026 earnings release. See our latest analysis for Autodesk. Autodesk's recent news sits against a mixed share price backdrop, with a 19.49% 1 month share price return and 6.35% 7 day share price return, yet a year to date share price return that is...

Dyne Therapeutics (DYN) has drawn fresh investor attention after receiving U.S. Food and Drug Administration clearance to begin a Phase 1 trial of DYNE-302 for facioscapulohumeral muscular dystrophy, a rare muscle disease without approved treatments. See our latest analysis for Dyne Therapeutics. At a share price of $26.25, Dyne Therapeutics has seen strong recent momentum, with a 30 day share price return of 12.08% and a 1 year total shareholder return of 135.22%, which suggests investor...

Why Insmed Stock Is Back In Focus After Q2 Earnings Insmed (INSM) has moved back into the spotlight after second quarter 2026 earnings on 6 August. The company reported a sharply smaller net loss and raised its full year revenue guidance, which helped spark renewed investor interest. See our latest analysis for Insmed. Insmed’s recent earnings release and revenue guidance update have come after a strong 7 day share price return of 32.96% and a 90 day share price return of 26.19%. However, the...

Strategy stock has delivered a very large 3 year gain while the broader valuation checks still lean cautious. This leaves investors weighing a strong historical return against signals that the shares are not clearly cheap. Over the past 3 years Strategy has returned about 160%, which shows how powerful the move has been for long term holders despite deeper recent drawdowns. The key driver for how the stock is priced remains market confidence in Strategy's Bitcoin centric treasury model. At...

Callaway Golf stock has more than doubled over the past year, yet the valuation signals are pulling in different directions. The Discounted Cash Flow (DCF) intrinsic value estimate points to the shares trading below fair value, while earnings-based multiples and broader checks suggest the stock is not a clear bargain. Callaway Golf has delivered a 104.5% return over the past year, which puts extra focus on whether the current price still leaves room for upside. Stronger recent sales and...

The market loved Mammoth Energy Services today. The stock jumped about 15% from the prior close, even though the headline number was a small loss from continuing operations in the quarter. That move is all about one thing: investors are voting that the emerging profitability story in this once distressed energy services platform matters more than the latest red ink. Coming into the release, Mammoth Energy Services had already logged strong recent gains. The new spark is Q2 revenue of about...

Kratos Defense & Security Solutions (KTOS) has drawn fresh attention after a series of contracts and capacity milestones, capped by second quarter earnings and a raise to full year 2026 revenue guidance into the US$1.75b to US$1.81b range. See our latest analysis for Kratos Defense & Security Solutions. The recent contract wins, capacity additions and raised 2026 revenue guidance have coincided with a sharp swing in sentiment. Kratos Defense & Security Solutions has posted a 7 day share price...

Why Tyler Technologies Stock Is Back In Focus Tyler Technologies (TYL) is back on many watchlists after a busy stretch that included record SaaS bookings, a large Tennessee cloud deployment, fresh share repurchases, and a recent convertible debt offering. See our latest analysis for Tyler Technologies. The recent Tennessee cloud deployment, record SaaS bookings, and fresh buybacks have put Tyler Technologies back in the spotlight, even though the share price is down 28.31% year to date and...

Ellington Financial Inc. recently reported second-quarter 2026 results, posting net income of US$58.61 million, or US$0.43 per diluted share from continuing operations, and US$163.92 million, or US$1.21 per diluted share, for the first half of the year. Beyond the headline earnings, adjusted distributable earnings exceeded the quarterly dividend while Longbridge’s reverse mortgage originations grew and a residential loan-servicer acquisition advanced, underscoring management’s focus on...

Why Veeco Instruments Stock Is Back on Investors’ Radar Veeco Instruments (VECO) has drawn fresh attention after reporting second quarter results, revising its 2026 outlook, landing about US$200 million in AI related advanced packaging orders, and announcing a LUMINA+ MOCVD win with a leading optical photonics customer. See our latest analysis for Veeco Instruments. Despite some recent volatility, with the 30 day share price return down 8.04% and the 90 day share price return down 13.76%,...

Johnson & Johnson stock has delivered a 69.3% total return over the past five years, while current valuation checks send a mixed message, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside and earnings-based multiples looking less generous. Over the last five years, Johnson & Johnson has returned 69.3%, which puts more focus on whether today’s price still offers a margin of safety. Progress in higher value medicines, including recent U.S. FDA Priority Review for...

AI and semiconductor supply chains are pulling in huge volumes of high grade electronics and power equipment, and that demand leans heavily on silver as a critical material. For investors, this creates a rare link between long term tech growth and a finite resource. This article walks through that dynamic and highlights three of the strongest candidates from the Top Silver Stocks screener that may be worth a closer look. The three stocks covered below are only a sample from the idea. The full...

Waystar Holding stock reacts to stronger Q2 update and outlook Waystar Holding (WAY) has been in focus after reporting Q2 2026 results that highlighted stronger revenue and earnings, supported by demand for its AI powered healthcare payments platform and larger client wins. The company also raised full year 2026 revenue and adjusted EBITDA guidance and outlined several large health system contracts. These updates, alongside recent share repurchases, give investors fresh data points to...

EOG Resources, Inc. reported past second-quarter 2026 results showing revenue of US$8.62 billion and net income of US$2.72 billion, with basic earnings per share from continuing operations of US$5.18. The company coupled this strong quarterly performance with higher production volumes, reaffirmed full-year guidance, a regular US$1.02-per-share dividend, and encouraging early unconventional exploration results in the United Arab Emirates. Next, we’ll examine how these stronger earnings and...